The Effect of Zoledronic Acid on Bone Microarchitecture and Strength after Denosumab and Teriparatide Administration: DATA‐HD Study Extension

The combination of denosumab and teriparatide is an effective treatment strategy in postmenopausal osteoporosis, though skeletal gains are promptly lost when these agents are discontinued. In the DATA‐HD study, we reported that a single dose of zoledronic acid (ZOL) maintains the increases in areal...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramchand, Sabashini K., David, Natalie L., Lee, Hang, Bruce, Michael, Bouxsein, Mary L., Tsai, Joy N., Leder, Benjamin Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Clinical Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098948/
https://www.ncbi.nlm.nih.gov/pubmed/36333954
http://dx.doi.org/10.1002/jbmr.4737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098948/
https://www.ncbi.nlm.nih.gov/pubmed/36333954
http://dx.doi.org/10.1002/jbmr.4737

Ejemplares similares